THU-366 - The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

Autor: Boursier, J., Vergniol, J., Lannes, A., Hiriart, J.-B., Oberti, F., Le Bail, B., Michalak, S., Chermak, F., Bertrais, S., Foucher, J., Fouchard-Hubert, I., Charbonnier, M., Rousselet, M.-C., Cales, P., de Ledinghen, V.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S161-S162
Databáze: ScienceDirect